Drug intelligence / Profile preview

Runing Capsules

Development stage: Unknown
Lead developer: Hefei Huafang Pharmaceutical Technology
Administration: Oral

Overview

Runing Capsules (乳宁胶囊) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Hefei Huafang Pharmaceutical Technology. It is primarily indicated for the treatment of breast hyperplasia (lobular hyperplasia of the breast) and associated symptoms such as breast pain (mastalgia) and the presence of lumps. The formulation is designed to warm the kidney, dispel cold, activate blood circulation, and resolve masses, following traditional therapeutic principles. It typically contains extracts from herbs such as *Epimedium*, *Curculigo*, *Psoralea*, and *Salvia miltiorrhiza*. The drug is approved for clinical use in China and is administered orally in capsule form.

Brand names: Runing Capsules乳宁胶囊
Other names: Ru Ning Jiao Nang

Beyond the preview

Go deeper on Runing Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Runing Capsules.

Explore the full profile